CD4-positive diffuse large B-cell lymphoma: A variant with aggressive clinical potential.
CD4 expression is rare in diffuse large B-cell lymphoma (DLBCL), with 4 previously reported cases. Its significance is uncertain. We report five patients with CD4(+) DLBCL and one CD4(+) primary mediastinal large B-cell lymphoma. Cases were identified by searching the electronic database of the department; each was reviewed. Average age was 56 years. Neoplastic cells expressed CD20 (5/6 tested cases). BCL2/BCL6 expression were seen in 3/3 tested cases, suggesting a germinal center origin. Additionally, expression of T-cell antigens CD2 and CD5 was noted in 2/2 and CD7 in 1/1 tested case. CD3 was negative in all. Lymph nodes were commonly involved (67%). Patients received chemotherapy +/- radiation (6/6) and bone marrow transplant (2/6). Average survival was 44.2 mo. CD4 expression in DLBCL raises questions of lineage commitment. CD4(+) DLBCL is rare; care should be exercised not to diagnose these as T-cell lymphomas. A subset behaves aggressively.
Mohammad O Hussaini, Division of Molecular Pathology, Department of Pathology and Immunology, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, United States.
Mohammad O
MO
Hussaini
Mohammad O Hussaini, Division of Molecular Pathology, Department of Pathology and Immunology, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, United States.
Friederike H
FH
Kreisel
Mohammad O Hussaini, Division of Molecular Pathology, Department of Pathology and Immunology, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, United States.
Anjum
A
Hassan
Mohammad O Hussaini, Division of Molecular Pathology, Department of Pathology and Immunology, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, United States.
TuDung T
TT
Nguyen
Mohammad O Hussaini, Division of Molecular Pathology, Department of Pathology and Immunology, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, United States.
John L
JL
Frater
CD4+; Diffuse large B-cell lymphoma; Lineage infidelity; T-cell lymphoma
Nat Immunol. 2007 May;8(5):463-70
17440452
Nature. 2007 Sep 27;449(7161):473-7
17851532
J Immunol. 2008 Feb 1;180(3):1719-28
18209069
Blood. 1980 Jan;55(1):16-20
6965347
Nature. 1977 Jul 21;268(5617):243-5
407477
Int J Hematol. 2010 Jul;92(1):198-203
20577835
Transplant Proc. 2001 Feb-Mar;33(1-2):784-5
11267070
Mod Pathol. 2007 Mar;20(3):310-9
17277765
J Pediatr Hematol Oncol. 2009 Feb;31(2):124-7
19194198
Br J Haematol. 2000 Jun;109(3):592-9
10886209
Am J Surg Pathol. 2009 Apr;33(4):505-12
19011566
Am J Clin Pathol. 2001 Mar;115(3):396-403
11242796
J Exp Med. 1981 Nov 1;154(5):1709-14
6975352
Am J Hematol. 2007 Jan;82(1):73-6
17019687
Rinsho Ketsueki. 2009 Jul;50(7):568-73
19638725
Am J Clin Pathol. 2009 Aug;132(2):186-90; quiz 306
19605812
Nature. 1999 Oct 7;401(6753):556-62
10524622